Petrol, Diesel Prices See Slight Uptick In Chennai On June 17; Here's How Much You Pay For Fuel In Your City
Fuel rates held steady on Wednesday, unchanged across most metros except for Chennai which saw a mild increase in rates. The last major revision in petrol prices was in March 2024, when the rate was cut by Rs 2 per litre.
Here are the updates on the petrol and diesel prices on June 17, 2025: In Delhi, a litre of petrol is retailed at Rs 94.77, and diesel costs Rs 87.67. In Mumbai, petrol is priced at Rs 103.50 per litre, and diesel costs Rs 90.03. In Chennai petrol is now sold at Rs 100.93 a litre, and diesel costs Rs 92.52. Petrol is sold at Rs 105.41 in Kolkata, and diesel is priced at Rs 92.02.
In India, fuel prices have remained steady since May 2022, after the central government and various state governments reduced fuel taxes.
Currently, oil marketing companies such as state-run Indian Oil Corporation review the domestic prices of petrol and diesel on a daily basis, and any changes – determined broadly by the global crude oil prices and the foreign exchange rates – are effected at the fuel stations at 6 a.m.
The price revisions method, or the dynamic fuel price methodology, considers several factors such as international crude prices, the exchange rate of the rupee against the dollar, actual and expected demand, and the trade flow in global crude markets.
According to Bloomberg, oil rose after jumping to the highest level in almost five months on Tuesday, as President Donald Trump fueled speculation that the US may join the attack on Iran, raising concerns over Middle East supply disruptions.
West Texas Intermediate gained as much as 1.1% to trade above $75 a barrel earlier. Brent settled near $76 in the previous session, Bloomberg reported.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.